Defining the Sympathetic Skin Response of Migraineurs in the Facial Area
Launched by HILLEL YAFFE MEDICAL CENTER · Dec 10, 2018
Trial Information
Current as of August 27, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy volunteers with no history of any kind of recurrent headache
- • Migraine patients according to ICH3 criteria
- • Migraine patients with more than 1 attack per month
- Exclusion Criteria:
- • Patients with other heart or neurologic diseases
- • Patients with hearing or visual decline
- • Patients taking medication that effects the sympathetic system (except those taking beta blockers for migraine treatment)
About Hillel Yaffe Medical Center
Hillel Yaffe Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Hadera, Israel, the center is committed to fostering cutting-edge scientific inquiry and collaboration across various medical disciplines. With a focus on patient safety and ethical standards, Hillel Yaffe Medical Center actively engages in the development of novel therapies and treatment modalities, aiming to enhance health outcomes and contribute to the global medical community. The center prides itself on its multidisciplinary approach, integrating expertise from experienced researchers and clinicians to drive impactful studies that address critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hadera, , Israel
Patients applied
Trial Officials
Yaron River, MD
Study Director
Hillel Yaffe Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials